Icon
+91 94997 68112
Login Register

Delzicol - (400mg; Capsule, Delayed Release)

MESALAMINE Allergan
400mg; Capsule, Delayed Release
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
 None
Less Than 5
Less Than 5
Treatment of mildly to moderately active ulcerative colitis (UC) in patients 12 years of age and older and for the maintenance of remission of UC in adults.
Yes
**** *** ***** *** *** ***** ** **** **** ** **** ****** '***- *** **, **** *** *** ************ *********. ** ****** **** **** **** ******* ** *** ****. ******* ***** ****** **** ***** **** ** **** *** **** ****** *** *** ************ *********. ******* ****** *** ********** ** ** ****** **** ********** *** ******* **** ******, ********* ** *** ***** ** ***** ****** *** ****** *** ******* ** ***** *, **** ** ******* ***** ******* *************. ***** ***** ********* *** ******** ** **** *** '*** ******. ************, **** ******* *** **** *** *** *********. *****, ** ******* *** ********* ** ***-************ ** ****** ******* **** *** ***** ***** *** ******** ** ****** ******** ** *** ******* *******. *** ********** *** ***** ******* **** ***** ***** *** ***** ** ********* *** *** ***** *** ** ****** ** ** ****** ** **** **** ****** ******. ********** **** **** ********* ** *** ******* ******* ***** *** ******* *** ** ******** ** *** ****. ** *** ****** ** ****** ***-********* ** **** *** ** **** ******** ******* **** ***** & ****** *** ****** **** ***** ****.
Delzicol Patent 1
**** *** *** ****
***** *******
***** ****** *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** \ ** *** **, **** *** *** **** ******** ******** ** *** **, ****
***** ** \ ** *** *, **** ******* **** **** ********
***** ****** ** \ ** *** *, **** ******* **** **** ********
  1. *** **, **** : **** ******** ****** ******** ***** *** **** ** **** ****** '***- *** **, ****.
  2. *** **, **** : ****** ******** ***** * ********** ******* **** ** ******** ***** ** ******* ******** ** ***** ******** ********.
  3. *** **, **** : ***** ******** ****** ******** ***** *** **** ** **** ****** '***- *** **, ****.
  4. *** *, **** : ****** ******** ***** * **** ******* ***** ** ******** ***** ** ******* ******** ** ***** ******** ********.
  5. *** *, **** : ****** ******** ***** * **** ******* ***** ****** ** ******* ******** ** ***** ******** ******** ** ***** ****** ***** **** ** **** ****** '***- *** **, ****.
  6. *** *, **** : ***** ***** *** ** **** *** *,***,*** -** ******
  7. *** *, **** : **** ******* ***** ** ****** **** **********.
  8. *** *, **** : **** ********* ******* **** ** *** ******* ** ***** **** **** ** ************* **** '*** ******.
  9. *** **, **** : ******** & ********* **** **** ** ** ** ******* ******** ** *****
  10. *** **, **** : *** ** ***** ** ***** ** **** *** ***** *** **** *** ********* ** ***-************.
  11. *** **, **** : ****** ******** ***** ** ****** ** ******* *******.
  12. *** **, **** : ********** *** ********* **** ***** ***** *** ***** ** ********* *** *** *****.
  13. *** **, **** : **** ******** ******* ******** ** **

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.